Slide 1: BASF Conference Call: Q1 2025
BASF Conference Call: Q1 2025 May 2, 2025
Slide 2: Cautionary note regarding forward-looking statements
Cautionary note regarding forward-looking statements This presentation contains forward-looking statements. These statements are based on current estimates and projections of the Board of Executive Directors and currently available information. Forward-looking statements are not guarantees of the fu
Slide 3: Strong local production footprint in all regions gives BASF resilience
Strong local production footprint in all regions gives BASF resilience Europe North America Asia Pacific1 South America, Africa, Middle East Share of sales from locally manufactured ~90% ~90% ~80% ~80% products in 2024 Share of BASF Group 38% 27% 25% 10% sales in 20242 Volume development ▲ +2% ▼ -9%
Slide 4: EBITDA before special items in Q1 2025 nearly at prior-year quarter level
EBITDA before special items in Q1 2025 nearly at prior-year quarter level Sales development ▪ Adjusted sales1 of €15.9 billion and Q1 2025 vs. Q1 2024 Volumes Prices Currency Portfolio reported sales1 of €17.4 billion almost stable BASF Group adjusted1 ▼ -1.1% ▼ -0.4% ▲ 0.3% ▲ 0.2% BASF Group IFRS1
Slide 5: Q1 2025: Earnings in Surface Technologies matched prior-year level, remaining segments below
Q1 2025: Earnings in Surface Technologies matched level of prior-year quarter, remaining segments came in below BASF Industrial Nutrition Surface Agricultural BASF Group Chemicals Materials Solutions1 & Care Technologies1 Solutions Other Group 2,712 278 2,625 -117 3 -39 -22 -32 EBITDA before -157 sp
Slide 6: BASF invests in semiconductor-grade sulfuric acid plant in Ludwigshafen
BASF invests in semiconductor-grade sulfuric acid plant in Ludwigshafen ▪ Strong demand for high-quality and high-purity semiconductor- grade chemicals ▪ New production facility in Ludwigshafen in proximity to key customer operations ▪ Mutual long-term customer- supplier commitments ▪ Startup expect
Slide 7: BASF Group Q1 2025: Key financial figures
BASF Group EBITDA before special items Adjusted EBITDA margin bsi1 Q1 2025: Key financial figures €2,625m 16.5% Q1 2025 vs. Q1 2024 -€87m -0.4ppt EBIT before special items Net income €1,664m €808m -€90m -€560m Operating cash flow Free cash flow -€982m -€1,798m -€468m -€342m 1 EBITDA margin before sp
Slide 8: Cash flow development in Q1 2025
Cash flow development in Q1 2025 Q1 2025 (million €) Q1 2024 (million €) Q1 2025 vs. Q1 2024 ▪ Cash flows from operating activities decreased by -€468 million to -€982 million, mainly due to build-up of -513 precious metals trading position and payment of €300 million for settlement -982 related to
Slide 9: Strong balance sheet
Strong balance sheet ▪ Total assets increased by €1.0 billion Million € March 31, 2025 Dec. 31, 2024 Change to €81.4 billion, mainly due to the seasonality of the Agricultural Solutions Total assets 81,419 80,415 1.2% business Noncurrent assets 48,228 49,183 -1.9% ▪ Equity ratio unchanged at 45.9% C
Slide 10: Maintaining our single A credit rating
Maintaining our single A credit rating Long-/short- ▪ BASF enjoys good credit ratings, Rating agency Outlook Last update particularly compared with competitors term rating ▪ BASF strives to maintain its single A Fitch A/F1 stable November 1, 2024 rating, which ensures unrestricted access to financia
Slide 11: Outlook 2025 for BASF Group remains unchanged
Outlook 2025 for BASF Group remains unchanged BASF Group 2024 BASF Group 2025 Zhanjiang startup actual forecast impact 20251 EBITDA before special 7.9 8.0 – 8.4 minus ~0.4 items (billion €) Free cash flow 0.7 0.4 – 0.8 minus ~0.8 (billion €) CO2 emissions2 17.0 16.7 – 17.7 (million metric tons) Unde
Slide 12: BASF - We create chemistry
O- BASF We create chemistry
Slide 13: BASF Group Q1 2025 vs. Q1 2024: Financial figures
BASF Group Q1 2025 vs. Q1 2024: Financial figures Financial figures Q1 2025 Q1 2024 Change Million € Million € % Sales 17,402 17,553 -0.9 EBITDA before special items 2,625 2,712 -3.2 EBITDA 2,177 2,655 -18.0 EBIT before special items 1,664 1,754 -5.1 EBIT 1,197 1,689 -29.2 Net income from shareholdi
Slide 14: Chemicals
Chemicals EBITDA before special items (million €) Segment cash flow (million €) 453 444 342 336 -406 -363 -390 -556 103 -726 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Sales development Total Volumes Prices Currencies Portfolio Q1 2025 vs. Q1 2024 ▲ 0.4% ▼ -2.3%
Slide 15: Materials
Materials EBITDA before special items (million €) Segment cash flow (million €) 508 484 448 469 299 246 365 137 85 44 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Sales development Total Volumes Prices Currencies Portfolio Q1 2025 vs. Q1 2024 ▲ 0.2% 0.0% ▼ -0.3% ▲
Slide 16: Industrial Solutions
Industrial Solutions EBITDA before special items1 (million €) Segment cash flow1 (million €) 383 378 367 361 416 308 403 167 142 117 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Sales development Total Volumes Prices Currencies Portfolio Q1 2025 vs. Q1 2024 ▼ -0.7%
Slide 17: Nutrition & Care
Nutrition & Care EBITDA before special items (million €) Segment cash flow (million €) 52 19 262 230 201 183 168 -38 -64 -103 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Sales development Total Volumes Prices Currencies Portfolio Q1 2025 vs. Q1 2024 ▼ -0.6% ▼ -3.4
Slide 18: Surface Technologies
Surface Technologies EBITDA before special items1 (million €) Segment cash flow1 (million €) 234 319 304 307 264 173 185 211 98 33 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Sales development Total Volumes Prices Currencies Portfolio Q1 2025 vs. Q1 2024 ▼ -1.2% ▲
Slide 19: Agricultural Solutions
Agricultural Solutions EBITDA before special items (million €) Segment cash flow (million €) 1,361 1,204 1,005 959 612 394 -715 135 -978 49 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Sales development Total Volumes Prices Currencies Portfolio Q1 2025 vs. Q1 2024
Slide 20: Review of "Other"
Review of “Other” Financial figures Q1 2025 Q1 2024 Change Million € Million € % Sales 903 736 22.7 EBITDA before special items -282 -560 49.7 of which Costs of corporate research -47 -53 11.5 Costs of corporate headquarters -59 -60 2.2 Other businesses 11 10 18.3 Miscellaneous income and expenses -